ADI Stock Recent News
ADI LATEST HEADLINES
WILMINGTON, Mass. , July 24, 2024 /PRNewswire/ -- July 24, 2024-- Analog Devices, Inc. (Nasdaq: ADI ) today announced it will release financial results for the third quarter fiscal year 2024 at 7:00 a.m.
The Nasdaq 100 is a list of the 100 most valuable companies traded on the Nasdaq index as measured by market capitalization. The Nasdaq index is generally associated with the technology sector.
Nanotech stocks remain at the forefront of every tech-savvy investor's portfolio, considering the predicted worldwide nanotechnology market size in 2024 is $91.18 billion. Analysts project market size will reach $332.73 billion by 2032, with a CAGR of 17.6%.
In the most recent trading session, Analog Devices (ADI) closed at $237.72, indicating a -0.35% shift from the previous trading day.
These companies are some of the best picks for semiconductor stocks to buy now. It's an interesting time for companies in the semiconductor business.
In the fiercely competitive semiconductor industry, Nvidia Corp often captures the spotlight with its groundbreaking AI advancements. However, the industry's next major winners might not be the usual suspects.
In the most recent trading session, Analog Devices (ADI) closed at $233.74, indicating a -1.93% shift from the previous trading day.
There are more than 3,500 publicly listed companies in the U.S. today. Yet a handful of stocks get all the attention from the media, analysts and investors.
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to evaluate ADI-270, an armored allogeneic “off-the-shelf” gamma delta chimeric antigen receptor (CAR) T cell therapy candidate targeting CD70.
Analog Devices (ADI) reported earnings 30 days ago. What's next for the stock?